James Buchanan
Overview
Explore the profile of James Buchanan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smith H, Regier D, Goranitis I, Bourke M, IJzerman M, Degeling K, et al.
Appl Health Econ Health Policy
. 2025 Jan;
PMID: 39832089
Introduction: Genomic medicine has features that make it preference sensitive and amenable to model-based health economic evaluation. Preferences of patients, caregivers, and clinicians related to the uptake and delivery of...
2.
Hamoodi Z, Shapiro J, Sayers A, Whitehouse M, Watts A, Abbott J, et al.
Bone Joint J
. 2024 Dec;
106-B(12):1461-1468.
PMID: 39618239
Aims: The aim of this audit was to assess and improve the completeness and accuracy of the National Joint Registry (NJR) dataset for arthroplasty of the elbow. Methods: It was...
3.
Santos Gonzalez F, Ungar W, Buchanan J, Christodoulou J, Stark Z, Goranitis I
Genet Med
. 2024 Nov;
27(2):101310.
PMID: 39522058
No abstract available.
4.
Health Care Costs After Genome-Wide Sequencing for Children With Rare Diseases in England and Canada
Weymann D, Buckell J, Fahr P, Loewen R, Ehman M, Pollard S, et al.
JAMA Netw Open
. 2024 Jul;
7(7):e2420842.
PMID: 38985473
Importance: Etiologic diagnoses for rare diseases can involve a diagnostic odyssey, with repeated health care interactions and inconclusive diagnostics. Prior studies reported cost savings associated with genome-wide sequencing (GWS) compared...
5.
Baple E, Scott R, Banka S, Buchanan J, Fish L, Wynn S, et al.
Nat Med
. 2024 Jun;
30(7):1823-1825.
PMID: 38898121
No abstract available.
6.
Roope L, Morrell L, Buchanan J, Ledda A, Adler A, Jit M, et al.
Commun Med (Lond)
. 2024 May;
4(1):101.
PMID: 38796507
Bacteria are becoming increasingly resistant to antibiotics, reducing our ability to treat infections and threatening to undermine modern health care. Optimising antibiotic use is a key element in tackling the...
7.
Marshall D, Hua N, Buchanan J, Christensen K, Frederix G, Goranitis I, et al.
Health Aff Sch
. 2024 May;
2(5):qxae053.
PMID: 38783891
Despite the emerging evidence in recent years, successful implementation of clinical genomic sequencing (CGS) remains limited and is challenged by a range of barriers. These include a lack of standardized...
8.
Silverman A, Sushil M, Bhasuran B, Ludwig D, Buchanan J, Racz R, et al.
Clin Pharmacol Ther
. 2024 Mar;
115(6):1391-1399.
PMID: 38459719
Outpatient clinical notes are a rich source of information regarding drug safety. However, data in these notes are currently underutilized for pharmacovigilance due to methodological limitations in text mining. Large...
9.
Nolan J, Buchanan J, Taylor J, Almeida J, Bedenham T, Blair E, et al.
Genet Med
. 2023 Dec;
26(3):101051.
PMID: 38131308
Purpose: The UK 100,000 Genomes Project offered participants screening for additional findings (AFs) in genes associated with familial hypercholesterolemia (FH) or hereditary cancer syndromes including breast/ovarian cancer (HBOC), Lynch, familial...
10.
Pan T, Wu Y, Buchanan J, Goranitis I
Health Qual Life Outcomes
. 2023 Dec;
21(1):132.
PMID: 38087302
Background: Genomic testing transforms the diagnosis and management of rare conditions. However, uncertainty exists on how to best measure genomic outcomes for informing healthcare priorities. Using the HTA-preferred method should...